Real-world results: Swiss hospitals saw strong mental health improvements in patients given LSD or psilocybin with psychotherapy under a compassionate use program. Safe in clinics: No serious side ...

Add Yahoo as a preferred source to see more of our stories on Google. Better moods, higher concentration levels, more creativity - and all without the usual risks associated with hard drugs: ...

A single dose of the psychedelic drug LSD seems to reduce anxiety without lasting side effects. “Ours is the first modern trial to look specifically at LSD, or any psychedelic, for generalised anxiety ...

MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...

Sept. 4 (UPI) --A study of a pharmaceutical form of the psychedelic drug lysergic acid diethylamide suggests it might relieve anxiety symptoms for up to three months. The results of a preliminary ...

Psychedelic drugs, such as lysergic acid diethylamide (LSD), can increase neuronal growth, which can have therapeutic effects for conditions such as schizophrenia. However, such drugs can induce ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — LSD reduced symptoms of ...

Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...

(NEW YORK) — Once a symbol of 1960s counterculture, the drug lysergic acid diethylamide, commonly known as LSD, is emerging from research labs as a possible treatment for anxiety. Preliminary trial ...

Dr Albert Hofmann accidentally discovered the hallucinatory effects of LSD in April 1943. In 1986, he told the BBC about a "terrifying" bicycle ride home from the laboratory.

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...